STATS ChipPAC:Much awaited reorg but 1Q16earnings surprises to downside;Maintain Hold

    来源: 德意志银行 作者:Vikash Agarwalla

    摘要: STATSChipPAC(STATS)recentlyannouncedFY15and1Q16resultsalongwithitsparentcompanyJCET.Apartfromearning

      STATS ChipPAC (STATS) recently announced FY15 and 1Q16 results alongwith its parent company JCET. Apart from earnings, JCET also announcedmuch awaited corporate reorganization. In this report we present our thoughtson recent developments as well as our updated bond views.

      Much awaited reorganization announcement

      JCET announced that it has entered into agreement with SMIC and IC Fund toswap their stake in STATS with stake in JCET. Additionally, SMIC announcedto subscribe to further stake in JCET with total proceed of RMB2.7 billion(~USD400 million). In terms of next steps, two key approvals are required 1)from the board and shareholders of JCET and 2) from CSRC. Post thetransaction completion, SMIC will effectively become the single largestshareholder of JCET with 14.26% stake. IC Fund will hold 9.5% stake in JCET.Xinchao Group’s stake in JCET will reduced to 14% (from 18.4%) withremaining being public holding.

      Share swap reorganization is not totally surprising as STATS has indicated thisin the past and we had highlighted the same in our initiation note in Nov, 2015.However, additional equity stake leading to money injection in JCET iscertainly positive from 1) emphasizing SMIC & IC Fund commitment to theGroup and 2) improving liquidity for the consolidated group. New equityinjection largely takes away concern around potential refinancing risk, in ourview. Thus, despite SMIC and IC Fund’s ownership in STATS changing fromdirect to indirect we view this development as slightly positive overall. It is alsoworth highlighting that SMIC & the IC Fund’s total combined investment in thegroup now stands at ~USD800 million (including new equity subscription).

      Earnings announcement - 1Q16 is weaker than expected

      Looking at standalone STATS numbers, 4Q15 results were largely stable but1Q16 is quite weak primarily driven by larger than expected decline in revenue.1Q16 revenue of USD244 million is 20% lower QoQ and 34% lower YoY. Thisled to company reporting gross loss of USD5 million for 1Q16. 1Q is seasonallylow but large part of revenue decline was on account of dismal semiconductordemand particularly for smart phones as well as inventory correction by somecustomers. EBITDA dropped to USD35 million (USD 63 million in 4Q15) as aresult of lower revenue.

      OCF (pre interest expense) dropped to USD20 million (compared to USD47million in 4Q15). Capex was relatively subdued at USD35 million (compared toUSD54 million in 4Q15) though still large enough for negative FCF. Total debtstands at USD1.1 billion and company has subsequently completedrefinancing of bridge loan through take out facility (USD315 million facilitycomprising of USD268 million TL and USD47 million of RCF ) in Apr, 2016.Cash balance declined to USD97 million at the end of 1Q16 compared toUSD118 million at the end of 2015 end.

      What to expect for rest of 2016

      Looking ahead, company has indicated that business has picked up slightly in2Q16 and early indication from customers seems to suggest potential furtherdemand/revenue pickup in 2H16. It continues to remain optimistic on potentialorder from new Chinese customers post the acquisition by JCET. As regards capex, it expects to incur USD260 million with substantial portion to be usedfor expansion of its eWLB capacity in Singapore.

      We remain cautious on industry demand and do believe that any new orderfrom Chinese customers would likely be only towards the end of 2016. In sucha scenario, capex program does look aggressive on a standalone basis. Thatsaid, we understand that capex program is contingent on support by JCET(estimated USD200 million from the new equity subscription by SMIC).

      Credit ratings

      Moodys downgraded STATS rating by one notch to B2 post 1Q16 results.More importantly it has maintained outlook as negative. Key downgradetriggers include 1) debt/EBITDA above 5.5x, 2) cash balance falling belowUSD75 million and 3) doesn’t receive USD200 million capital injection forcapex. Looking at 1Q16 numbers, downgrade triggers could be breached evenif there is slight pick-up in EBITDA in subsequent quarters. That said, our basecase is capital injection by JCET and pick up in revenue and profitabilityleading to outlook returning stable.

      S&P on the other hand currently has rating at BB- with stable outlook.

      Downgrade triggers include 1) debt/EBITDA of more than 4x, 2) YoY decline inrevenue and EBITDA, 3) loss of any major customer and 4) aggressive capexspending. Based on 1Q16 numbers and 2016 capex guidance, three out of fourtriggers will likely be breached. However, S&P is relatively more sanguine onparental support, in our view, and would likely consider the new equityinjection in JCET more positively. Overall, we will not be surprised to seeoutlook changed to negative though S&P may wait to see recovery insubsequent quarters before downgrading the rating.

      Bonds view

      STATS 2020 ($99.75/100.5; ask ytm of 8.4%) has done well post the lows inFeb this year. Bonds remained fairly stable post earnings and reorganizationannouncement but have come off by ~1.5 points since Moodys downgradeyesterday. We had turned neutral last week as it looked relatively faircompared to global peer. We continue to be cautious on capex intensivecyclical industry though industry risk is somewhat offset by potential policyand parental support in STATS’ case.

      As regards regional comparables, there seems to be some upside compared toother SOE linked HY names such as Zoomlion 22 (ask price of 84.5; ask ytm of9.3%), West China 19C17 (ask price of 105.5; ask ytw of 4.6%). But suchnames have better China onshore investor support which is still not very strongfor STATS in our view. Even STATS’ structure is inferior though it benefits frombeing a secured bond. Thus we maintain Hold.

      Key upside risks include better than expected pick-up in demand and potentialsynergies & new customer contracts in China. Key downside risks includefurther decline in revenue and EBITDA, loss of any contract/customer andfurther rating downgrade.

      

    关键词:

    However,inourview,Thatsaid,debt,STATSChipPAC

    审核:yj194 编辑:yj127

    免责声明:

    1:凡本网注明“来源:***”的作品,均是转载自其他平台,本网赢家财富网 www.yjcf360.com 转载文章为个人学习、研究或者欣赏传播信息之目的,并不意味着赞同其观点或其内容的真实性已得到证实。全部作品仅代表作者本人的观点,不代表本网站赢家财富网的观点、看法及立场,文责作者自负。如因作品内容、版权和其他问题请与本站管理员联系,请在30日内进行,我们收到通知后会在3个工作日内及时进行处理。

    2:本网站刊载的各类文章、广告、访问者在本网站发表的观点,以链接形式推荐的其他网站内容,仅为提供更多信息供用户参考使用或为学习交流的方便(本网有权删除)。所提供的数据仅供参考,使用者务请核实,风险自负。

    版权属于赢家财富网,转载请注明出处
    查看更多
    • 内参
    • 股票
    • 赢家观点
    • 娱乐
    • 原创

    澳门拟简化私募基金落户申请程序

    据大湾区之声,澳门特区政府金融管理局表示,为配合私募基金业务发展,局方已与横琴粤澳深度合作区订定措施,便利具一定资质的私募基金管理公司落户澳门,目前亦正修订《...

    市场震荡加大 私募对冲策略优势显露

    ●本报记者朱涵在市场震荡幅度加大背景下,量化对冲私募优势凸显,相关产品净值逆势上扬。近日,部分量化私募对策略进行调整优化,使其更加适应市场变化。力争获得长期稳...

    申万宏源:A股反弹线索已明确

    申万宏源证券(000562)发布研报称,2024年经济展望五个“前高后低”,岁末年初经济向好本就是大概率。短期变化,强化了这个预期:三季度经济向好情况下,特别国债落地,...

    可孚医疗:全面自主掌控的销售渠道是可孚医疗核心竞争力之一

    消息,可孚医疗(301087)10月28日在投资者关系平台上答复投资者关心的问题。投资者:董秘你好,现在全球多国已关闭电商平台,公司一半以上营收靠电商,国内关闭电商呼声越...

    早知道:2023年10月27号热点概念与题材前瞻

      上证指数目前处于下跌趋势中的短线反弹,依据赢家江恩价格工具得出:当前支撑位:2922.39点、2885.09点,当前阻力位:3018.56点、3053.04点,由赢家江恩时间周期工具...

    早知道:2023年10月26号热点概念与题材前瞻

      上证指数目前处于下跌趋势中,依据赢家江恩价格工具得出:当前支撑位:2885.09点、2929.23点,当前阻力位:3018.56点、3053.04点,由赢家江恩时间周期工具展示得出:...

    IPO审核是如何进行的?大概多久?要满足什么条件?

    IPO即首次公开募股,是指公司或企业首次向公众出售其股份。这个概念大家都知道,也都知道,我国的公司要上市,最正式最重要的方式就是进行IPO审核,借壳上市姑且不提。这...

    艺术品信托是什么?艺术品信托是如何运作的?

    艺术品近年来逐渐成为人们关注的实物资产。与其他有形资产相比,艺术品具有特殊的属性。它们承载着创作者的智慧,时代的背景,历史赋予的文化价值。它们被人们认可、收藏...